Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Nephropathy Type 2”

295 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 295 results

Not applicableLooking for participantsNCT07485075
What this trial is testing

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Who this might be right for
Diabetes Type 2Kidney Disease
Steno Diabetes Center Copenhagen 104
Testing effectiveness (Phase 2)Study completedNCT06051565
What this trial is testing

Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients

Who this might be right for
DiabetesMagnetic Resonance Imaging
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 12
Post-approval studies (Phase 4)WithdrawnNCT03504566
What this trial is testing

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

Who this might be right for
Diabetic Nephropathy Type 2
Steno Diabetes Center Copenhagen
Large-scale testing (Phase 3)Study completedNCT03436693
What this trial is testing

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 308
Not applicableLooking for participantsNCT07169422
What this trial is testing

Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Nova Scotia Health Authority 120
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Not applicableStudy completedNCT03889236
What this trial is testing

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Who this might be right for
Diabetic Nephropathy Type 2AlbuminuriaType2 Diabetes Mellitus+7 more
Leiden University Medical Center 56
Not applicableStudy completedNCT00253786
What this trial is testing

Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy

Who this might be right for
Type 2 Diabetes MellitusDiabetic Nephropathy
Okayama University 312
Post-approval studies (Phase 4)Study completedNCT06224790
What this trial is testing

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Diabetic NephropathiesType 2 Diabetes
Sidrah Lodhi 60
Not applicableUnknownNCT05691985
What this trial is testing

Fib to Alb Ratio in Type 2 Dkd

Who this might be right for
CKDType 2 Diabetes
Assiut University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05759468
What this trial is testing

NAD Augmentation in Diabetes Kidney Disease

Who this might be right for
Type2diabetesDiabetic Kidney Disease
Brigham and Women's Hospital 156
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT01968668
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Who this might be right for
Diabetic Nephropathies
Bayer 96
Not applicableEnrolling By InvitationNCT05530356
What this trial is testing

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

Who this might be right for
Type 2 DiabetesDiabetes Type 2Diabetic Nephropathies+4 more
University of Colorado, Denver 100
Testing effectiveness (Phase 2)Study completedNCT05718375
What this trial is testing

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Who this might be right for
Diabetic Nephropathies
Curacle Co., Ltd. 240
Not applicableStudy completedNCT04403945
What this trial is testing

The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy

Who this might be right for
Microcirculation Detection in Diabetic Patients
Third Military Medical University 143
Not applicableStudy completedNCT07119892
What this trial is testing

Lifestyle Intervention and Its Effects on Inflammatory Cytokines and Oxidative Stress Markers in Diabetic Chronic Kidney Disease Patients: A Randomized Controlled Trial

Who this might be right for
Type 2 Diabetes MellitusInflammation, Chronic Low-GradeChronic Kidney Disease+2 more
Sinai University 60
Post-approval studies (Phase 4)Study completedNCT04027530
What this trial is testing

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseDiabetic Nephropathy+4 more
Amsterdam UMC, location VUmc 40
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Load More Results